Featured
Read our handpicked blogs, curated for you.
|
Why the pharma marketing stack is a boardroom issue now? You might think that! Well, Indian pharma has always been…
|
CMOs do not struggle to justify campaigns; they struggle to prove Marketing ROI with hard numbers the board trusts. If…
|
Pharma marketers in India know the frustration well. Campaigns stall not because the idea is weak, but because the…
Recent releases
|
How to Prove ROI of Your Pharma Marketing Budget in India
Pharma marketing in India is at a turning point. Budgets have expanded, channels have multiplied, and compliance demands have grown tighter. Yet, proving the ROI of a pharma marketing budget remains…
|
What Actually Works for HCP Engagement Tier 2 Cities?
If you’re serious about HCP Engagement Tier 2 Cities, stop chasing metro playbooks. Tier 2 doctors don’t sit in front of laptops reading email newsletters. They live on phones, juggle packed OPDs,…
|
Why Your HCP Engagement Fails Without a Unified Journey Map
Every pharma CMO in India knows the drill: you spend crores across channels, field reps log endless calls, marketing pushes campaigns, medical affairs approves content, and yet; you still can’t…
|
HCP Journey Mapping the Missing Link in Pharma Marketing ROI
HCP journey mapping is no longer optional. It is the backbone of omnichannel marketing pharma. Without it, campaigns collapse into silos and every rupee spent becomes hard to justify. Indian pharma…
